Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.33555736 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.33555736 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.21485353 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.21485353 |
5 | regulation of plasminogen activation (GO:0010755) | 5.93472771 |
6 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.79353253 |
7 | purine nucleotide salvage (GO:0032261) | 5.29087402 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.24320918 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.20046216 |
10 | sulfur amino acid catabolic process (GO:0000098) | 5.10052522 |
11 | cysteine metabolic process (GO:0006534) | 5.07766531 |
12 | glyoxylate metabolic process (GO:0046487) | 4.91256378 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.86712112 |
14 | lysine metabolic process (GO:0006553) | 4.79604925 |
15 | lysine catabolic process (GO:0006554) | 4.79604925 |
16 | kynurenine metabolic process (GO:0070189) | 4.63207757 |
17 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.62214094 |
18 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.62214094 |
19 | L-serine metabolic process (GO:0006563) | 4.56175680 |
20 | galactose catabolic process (GO:0019388) | 4.54960348 |
21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.47321585 |
22 | negative regulation of fibrinolysis (GO:0051918) | 4.47022958 |
23 | bile acid biosynthetic process (GO:0006699) | 4.42381564 |
24 | tryptophan catabolic process (GO:0006569) | 4.42073860 |
25 | indole-containing compound catabolic process (GO:0042436) | 4.42073860 |
26 | indolalkylamine catabolic process (GO:0046218) | 4.42073860 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.35340635 |
28 | urea metabolic process (GO:0019627) | 4.28495443 |
29 | urea cycle (GO:0000050) | 4.28495443 |
30 | regulation of cholesterol homeostasis (GO:2000188) | 4.24183082 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.20271778 |
32 | tryptophan metabolic process (GO:0006568) | 4.17898513 |
33 | protein carboxylation (GO:0018214) | 4.17451266 |
34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.17451266 |
35 | homocysteine metabolic process (GO:0050667) | 4.14925862 |
36 | complement activation, alternative pathway (GO:0006957) | 4.12285767 |
37 | glycine metabolic process (GO:0006544) | 4.11944557 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.11918519 |
39 | proline biosynthetic process (GO:0006561) | 4.10727341 |
40 | regulation of protein activation cascade (GO:2000257) | 4.10326317 |
41 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.09488232 |
42 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.08535435 |
43 | nucleotide salvage (GO:0043173) | 4.08511912 |
44 | cellular modified amino acid catabolic process (GO:0042219) | 4.04873183 |
45 | intestinal cholesterol absorption (GO:0030299) | 4.04511183 |
46 | valine metabolic process (GO:0006573) | 4.02624575 |
47 | regulation of fibrinolysis (GO:0051917) | 3.99707731 |
48 | reverse cholesterol transport (GO:0043691) | 3.97963807 |
49 | serine family amino acid metabolic process (GO:0009069) | 3.91594847 |
50 | nitrogen cycle metabolic process (GO:0071941) | 3.91427123 |
51 | bile acid metabolic process (GO:0008206) | 3.90618173 |
52 | negative regulation of cholesterol transport (GO:0032375) | 3.87872579 |
53 | negative regulation of sterol transport (GO:0032372) | 3.87872579 |
54 | proline metabolic process (GO:0006560) | 3.87093726 |
55 | serine family amino acid biosynthetic process (GO:0009070) | 3.85085703 |
56 | amino-acid betaine metabolic process (GO:0006577) | 3.85024343 |
57 | regulation of complement activation (GO:0030449) | 3.84444891 |
58 | phospholipid efflux (GO:0033700) | 3.82774347 |
59 | alpha-amino acid catabolic process (GO:1901606) | 3.80007507 |
60 | GDP-mannose metabolic process (GO:0019673) | 3.78716173 |
61 | triglyceride homeostasis (GO:0070328) | 3.78056120 |
62 | acylglycerol homeostasis (GO:0055090) | 3.78056120 |
63 | aromatic amino acid family metabolic process (GO:0009072) | 3.77926463 |
64 | Golgi transport vesicle coating (GO:0048200) | 3.77261129 |
65 | COPI coating of Golgi vesicle (GO:0048205) | 3.77261129 |
66 | 2-oxoglutarate metabolic process (GO:0006103) | 3.76557718 |
67 | negative regulation of cell size (GO:0045792) | 3.75652404 |
68 | protein-lipid complex remodeling (GO:0034368) | 3.75029938 |
69 | macromolecular complex remodeling (GO:0034367) | 3.75029938 |
70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.75029938 |
71 | 4-hydroxyproline metabolic process (GO:0019471) | 3.69084629 |
72 | IMP biosynthetic process (GO:0006188) | 3.66546352 |
73 | cellular amino acid catabolic process (GO:0009063) | 3.66472782 |
74 | mitochondrial RNA metabolic process (GO:0000959) | 3.64734397 |
75 | tricarboxylic acid metabolic process (GO:0072350) | 3.64626086 |
76 | regulation of cholesterol esterification (GO:0010872) | 3.64384362 |
77 | drug transmembrane transport (GO:0006855) | 3.64297284 |
78 | folic acid-containing compound metabolic process (GO:0006760) | 3.61996491 |
79 | ethanol oxidation (GO:0006069) | 3.60423728 |
80 | NADH metabolic process (GO:0006734) | 3.60361750 |
81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.59257694 |
82 | glutamate metabolic process (GO:0006536) | 3.54395214 |
83 | bile acid and bile salt transport (GO:0015721) | 3.53699018 |
84 | aspartate family amino acid catabolic process (GO:0009068) | 3.53544351 |
85 | regulation of superoxide anion generation (GO:0032928) | 3.52136644 |
86 | plasma lipoprotein particle clearance (GO:0034381) | 3.50437058 |
87 | regulation of cholesterol storage (GO:0010885) | 3.50189403 |
88 | protein maturation by protein folding (GO:0022417) | 3.50044668 |
89 | folic acid metabolic process (GO:0046655) | 3.48385903 |
90 | plasma lipoprotein particle assembly (GO:0034377) | 3.46615328 |
91 | fatty acid beta-oxidation (GO:0006635) | 3.44243481 |
92 | coenzyme catabolic process (GO:0009109) | 3.43761669 |
93 | tetrahydrofolate metabolic process (GO:0046653) | 3.43446608 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.42107534 |
95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.42107534 |
96 | short-chain fatty acid metabolic process (GO:0046459) | 3.41888481 |
97 | galactose metabolic process (GO:0006012) | 3.41809028 |
98 | fatty acid oxidation (GO:0019395) | 3.40434893 |
99 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.39716716 |
100 | tyrosine metabolic process (GO:0006570) | 3.36113099 |
101 | ribosome biogenesis (GO:0042254) | 3.35735320 |
102 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.35379617 |
103 | IMP metabolic process (GO:0046040) | 3.35186344 |
104 | desmosome organization (GO:0002934) | 3.34356179 |
105 | fatty acid catabolic process (GO:0009062) | 3.34287273 |
106 | lipid oxidation (GO:0034440) | 3.33837686 |
107 | phospholipid homeostasis (GO:0055091) | 3.32729958 |
108 | monocarboxylic acid catabolic process (GO:0072329) | 3.32722220 |
109 | carboxylic acid catabolic process (GO:0046395) | 3.31882019 |
110 | organic acid catabolic process (GO:0016054) | 3.31882019 |
111 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.28168132 |
112 | glycosphingolipid catabolic process (GO:0046479) | 3.27928664 |
113 | cholesterol homeostasis (GO:0042632) | 3.27419726 |
114 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.26465275 |
115 | cellular glucuronidation (GO:0052695) | 3.25759728 |
116 | flavonoid metabolic process (GO:0009812) | 3.25237882 |
117 | protein-lipid complex assembly (GO:0065005) | 3.24504765 |
118 | benzene-containing compound metabolic process (GO:0042537) | 3.24293330 |
119 | acetyl-CoA metabolic process (GO:0006084) | 3.22434023 |
120 | sterol homeostasis (GO:0055092) | 3.22192418 |
121 | response to vitamin A (GO:0033189) | 3.21317151 |
122 | cellular ketone body metabolic process (GO:0046950) | 3.19426937 |
123 | protein retention in ER lumen (GO:0006621) | 3.19381776 |
124 | urate metabolic process (GO:0046415) | 3.18819952 |
125 | imidazole-containing compound metabolic process (GO:0052803) | 3.17821878 |
126 | intestinal absorption (GO:0050892) | 3.17452650 |
127 | cholesterol efflux (GO:0033344) | 3.17246120 |
128 | peptidyl-arginine N-methylation (GO:0035246) | 3.16285927 |
129 | peptidyl-arginine methylation (GO:0018216) | 3.16285927 |
130 | drug transport (GO:0015893) | 3.16252921 |
131 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.14355136 |
132 | regulation of cholesterol metabolic process (GO:0090181) | 3.14191651 |
133 | drug catabolic process (GO:0042737) | 3.13615285 |
134 | peptidyl-proline hydroxylation (GO:0019511) | 3.13595087 |
135 | oxaloacetate metabolic process (GO:0006107) | 3.13589435 |
136 | histone arginine methylation (GO:0034969) | 3.11741996 |
137 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.11255795 |
138 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.09149799 |
139 | glycoside metabolic process (GO:0016137) | 3.05531142 |
140 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.04741851 |
141 | microtubule nucleation (GO:0007020) | 3.04307450 |
142 | regulation of vitamin metabolic process (GO:0030656) | 3.02578137 |
143 | glycolipid catabolic process (GO:0019377) | 3.01137081 |
144 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.01099742 |
145 | white fat cell differentiation (GO:0050872) | 3.00571977 |
146 | pteridine-containing compound metabolic process (GO:0042558) | 2.99392390 |
147 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.99172250 |
148 | negative regulation of necroptotic process (GO:0060546) | 2.98518481 |
149 | monosaccharide biosynthetic process (GO:0046364) | 2.97192707 |
150 | alpha-amino acid biosynthetic process (GO:1901607) | 2.95095608 |
151 | polyamine biosynthetic process (GO:0006596) | 2.94799091 |
152 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.91680109 |
153 | gluconeogenesis (GO:0006094) | 2.88672297 |
154 | pentose-phosphate shunt (GO:0006098) | 2.88515317 |
155 | hexose biosynthetic process (GO:0019319) | 2.79648658 |
156 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.79083984 |
157 | cellular protein complex localization (GO:0034629) | 2.71912742 |
158 | nucleoside transmembrane transport (GO:1901642) | 2.71016232 |
159 | pentose metabolic process (GO:0019321) | 2.69443483 |
160 | mitochondrial fusion (GO:0008053) | 2.68834107 |
161 | pinocytosis (GO:0006907) | 2.66555353 |
162 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.65780413 |
163 | tRNA modification (GO:0006400) | 2.65569478 |
164 | transcription from mitochondrial promoter (GO:0006390) | 2.64040591 |
165 | response to thyroid hormone (GO:0097066) | 2.60817492 |
166 | regulation of tight junction assembly (GO:2000810) | 2.60186249 |
167 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.58831831 |
168 | NADPH regeneration (GO:0006740) | 2.58303680 |
169 | cellular modified amino acid biosynthetic process (GO:0042398) | 2.56902983 |
170 | adenosine metabolic process (GO:0046085) | 2.55097111 |
171 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.54769772 |
172 | glucose catabolic process (GO:0006007) | 2.52873623 |
173 | protein hydroxylation (GO:0018126) | 2.52242782 |
174 | sulfur amino acid biosynthetic process (GO:0000097) | 2.51256762 |
175 | ceramide catabolic process (GO:0046514) | 2.49939131 |
176 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.49500925 |
177 | negative regulation of catenin import into nucleus (GO:0035414) | 2.48722216 |
178 | cell migration involved in heart development (GO:0060973) | 2.47112176 |
179 | pseudouridine synthesis (GO:0001522) | 2.45963051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.41736902 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.85584508 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.39763695 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76280047 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42417379 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.59890319 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.56160672 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.53656446 |
9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.42628698 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.21469198 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.92588071 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.75484004 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71278702 |
14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.41200527 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37205009 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.29452934 |
17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.21911588 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20937139 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08321210 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06926540 |
21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.00148224 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93766976 |
23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.87578542 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.80557212 |
25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77825645 |
26 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76585248 |
27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75118713 |
28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.72837184 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.70882922 |
30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.68993239 |
31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67592461 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65319352 |
33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65047062 |
34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63905381 |
35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.60202655 |
36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57743521 |
37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57285284 |
38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54547435 |
39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54538932 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53626125 |
41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47774126 |
42 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46427214 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40391580 |
44 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40001548 |
45 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39126593 |
46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38702628 |
47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38644437 |
48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38329715 |
49 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36708466 |
50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34141820 |
51 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33038273 |
52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32490245 |
53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31838876 |
54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26444134 |
55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25446250 |
56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25157622 |
57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24651400 |
58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24454453 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24185348 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21774635 |
61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21103116 |
62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20733735 |
63 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.20691579 |
64 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20318871 |
65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20218335 |
66 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.20052042 |
67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19602374 |
68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17407263 |
69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16818737 |
70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15321110 |
71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14867323 |
72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14827581 |
73 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.13978245 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13961425 |
75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13816549 |
76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13643910 |
77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12740342 |
78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11470520 |
79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11434223 |
80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09796326 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09530018 |
82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09443271 |
83 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09079761 |
84 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08712372 |
85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08497691 |
86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08455720 |
87 | MAF_26560356_Chip-Seq_TH1_Human | 1.08112677 |
88 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07850917 |
89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07330474 |
90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06757130 |
91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04719046 |
92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04309835 |
93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04268129 |
94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04153810 |
95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04051794 |
96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03434722 |
97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03307449 |
98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02778287 |
99 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02717291 |
100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02637770 |
101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02419071 |
102 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01857210 |
103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01786051 |
104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01755582 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01100457 |
106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01100062 |
107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00087955 |
108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99428825 |
109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99040163 |
110 | P68_20966046_ChIP-Seq_HELA_Human | 0.98809498 |
111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98223451 |
112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97755274 |
113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95753481 |
114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95357413 |
115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95205344 |
116 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94187286 |
117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94144637 |
118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93779303 |
119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93146106 |
120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92525230 |
121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91715202 |
122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91399831 |
123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90433912 |
124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90169049 |
125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89778808 |
126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89714125 |
127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88764046 |
128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87797815 |
129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87610035 |
130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87359164 |
131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86860909 |
132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86160645 |
133 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84725552 |
134 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.84109722 |
135 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83682074 |
136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83347648 |
137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83243613 |
138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83236061 |
139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82944842 |
140 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82886429 |
141 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82435503 |
142 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81923745 |
143 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81717880 |
144 | MAF_26560356_Chip-Seq_TH2_Human | 0.80405365 |
145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80348014 |
146 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79528578 |
147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79375329 |
148 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.79092856 |
149 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78809406 |
150 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.76773473 |
151 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76400937 |
152 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76355194 |
153 | MYB_26560356_Chip-Seq_TH1_Human | 0.76016293 |
154 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75611391 |
155 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.74122702 |
156 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.74034970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.52078998 |
2 | MP0005360_urolithiasis | 6.05551745 |
3 | MP0005365_abnormal_bile_salt | 5.31232875 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.79989899 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.59035144 |
6 | MP0009840_abnormal_foam_cell | 3.54533727 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.48207063 |
8 | MP0003252_abnormal_bile_duct | 3.39932968 |
9 | MP0005083_abnormal_biliary_tract | 3.16742726 |
10 | MP0001666_abnormal_nutrient_absorption | 3.08075091 |
11 | MP0010329_abnormal_lipoprotein_level | 2.97528283 |
12 | MP0004233_abnormal_muscle_weight | 2.58187284 |
13 | MP0005332_abnormal_amino_acid | 2.55676772 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.49887384 |
15 | MP0003195_calcinosis | 2.36957442 |
16 | MP0000609_abnormal_liver_physiology | 2.13203346 |
17 | MP0008260_abnormal_autophagy | 2.10448148 |
18 | MP0002396_abnormal_hematopoietic_system | 2.05324809 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.98138175 |
20 | MP0003868_abnormal_feces_composition | 1.92133576 |
21 | MP0000678_abnormal_parathyroid_gland | 1.87607789 |
22 | MP0002138_abnormal_hepatobiliary_system | 1.87224420 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.83273336 |
24 | MP0009643_abnormal_urine_homeostasis | 1.82397249 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.81144785 |
26 | MP0003693_abnormal_embryo_hatching | 1.75228254 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.75194928 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.75038061 |
29 | MP0005220_abnormal_exocrine_pancreas | 1.72453326 |
30 | MP0000858_altered_metastatic_potential | 1.71494956 |
31 | MP0003300_gastrointestinal_ulcer | 1.61169061 |
32 | MP0003111_abnormal_nucleus_morphology | 1.61068303 |
33 | MP0005076_abnormal_cell_differentiation | 1.55859910 |
34 | MP0005058_abnormal_lysosome_morphology | 1.51210908 |
35 | MP0000751_myopathy | 1.48896716 |
36 | MP0008438_abnormal_cutaneous_collagen | 1.48208491 |
37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40518818 |
38 | MP0001764_abnormal_homeostasis | 1.38829132 |
39 | MP0004858_abnormal_nervous_system | 1.38384306 |
40 | MP0002837_dystrophic_cardiac_calcinosis | 1.35916235 |
41 | MP0002132_abnormal_respiratory_system | 1.35158589 |
42 | MP0000750_abnormal_muscle_regeneration | 1.33265405 |
43 | MP0000598_abnormal_liver_morphology | 1.31203169 |
44 | MP0000759_abnormal_skeletal_muscle | 1.24014687 |
45 | MP0004264_abnormal_extraembryonic_tissu | 1.23686478 |
46 | MP0002078_abnormal_glucose_homeostasis | 1.21455866 |
47 | MP0006036_abnormal_mitochondrial_physio | 1.19641534 |
48 | MP0003656_abnormal_erythrocyte_physiolo | 1.19566212 |
49 | MP0003786_premature_aging | 1.18178598 |
50 | MP0005636_abnormal_mineral_homeostasis | 1.17248648 |
51 | MP0005670_abnormal_white_adipose | 1.17168211 |
52 | MP0004043_abnormal_pH_regulation | 1.14546422 |
53 | MP0001849_ear_inflammation | 1.11197557 |
54 | MP0001944_abnormal_pancreas_morphology | 1.10656247 |
55 | MP0001730_embryonic_growth_arrest | 1.10361674 |
56 | MP0005330_cardiomyopathy | 1.09393320 |
57 | MP0003436_decreased_susceptibility_to | 1.07305041 |
58 | MP0002693_abnormal_pancreas_physiology | 1.03228163 |
59 | MP0008469_abnormal_protein_level | 1.02784523 |
60 | MP0005084_abnormal_gallbladder_morpholo | 1.01844057 |
61 | MP0003186_abnormal_redox_activity | 1.00976329 |
62 | MP0000749_muscle_degeneration | 1.00675510 |
63 | MP0005646_abnormal_pituitary_gland | 1.00103759 |
64 | MP0009642_abnormal_blood_homeostasis | 0.98387018 |
65 | MP0005666_abnormal_adipose_tissue | 0.97812352 |
66 | MP0001756_abnormal_urination | 0.92381869 |
67 | MP0009763_increased_sensitivity_to | 0.92164363 |
68 | MP0000604_amyloidosis | 0.92124001 |
69 | MP0002928_abnormal_bile_duct | 0.91700961 |
70 | MP0003077_abnormal_cell_cycle | 0.90800354 |
71 | MP0005464_abnormal_platelet_physiology | 0.90427183 |
72 | MP0009115_abnormal_fat_cell | 0.89500366 |
73 | MP0001765_abnormal_ion_homeostasis | 0.89316084 |
74 | MP0008995_early_reproductive_senescence | 0.88078978 |
75 | MP0010094_abnormal_chromosome_stability | 0.87622877 |
76 | MP0005334_abnormal_fat_pad | 0.86368992 |
77 | MP0004087_abnormal_muscle_fiber | 0.85059897 |
78 | MP0002971_abnormal_brown_adipose | 0.84639159 |
79 | MP0000733_abnormal_muscle_development | 0.84512593 |
80 | MP0003646_muscle_fatigue | 0.84140639 |
81 | MP0006035_abnormal_mitochondrial_morpho | 0.84075631 |
82 | MP0010234_abnormal_vibrissa_follicle | 0.81821380 |
83 | MP0010368_abnormal_lymphatic_system | 0.81471743 |
84 | MP0000371_diluted_coat_color | 0.81176893 |
85 | MP0008932_abnormal_embryonic_tissue | 0.80923964 |
86 | MP0002909_abnormal_adrenal_gland | 0.79904112 |
87 | MP0002136_abnormal_kidney_physiology | 0.79002886 |
88 | MP0005375_adipose_tissue_phenotype | 0.77149934 |
89 | MP0004957_abnormal_blastocyst_morpholog | 0.76969814 |
90 | MP0004130_abnormal_muscle_cell | 0.76240320 |
91 | MP0000313_abnormal_cell_death | 0.75430067 |
92 | MP0001270_distended_abdomen | 0.74494398 |
93 | MP0003315_abnormal_perineum_morphology | 0.74349421 |
94 | MP0005501_abnormal_skin_physiology | 0.73856646 |
95 | MP0009764_decreased_sensitivity_to | 0.73834527 |
96 | MP0008058_abnormal_DNA_repair | 0.73676881 |
97 | MP0002269_muscular_atrophy | 0.72416601 |
98 | MP0000681_abnormal_thyroid_gland | 0.71144183 |
99 | MP0003763_abnormal_thymus_physiology | 0.71068396 |
100 | MP0005025_abnormal_response_to | 0.69634801 |
101 | MP0001845_abnormal_inflammatory_respons | 0.69559069 |
102 | MP0003638_abnormal_response/metabolism_ | 0.69465772 |
103 | MP0005451_abnormal_body_composition | 0.69197853 |
104 | MP0002089_abnormal_postnatal_growth/wei | 0.69071677 |
105 | MP0004185_abnormal_adipocyte_glucose | 0.69066497 |
106 | MP0006054_spinal_hemorrhage | 0.68806567 |
107 | MP0010630_abnormal_cardiac_muscle | 0.68116412 |
108 | MP0005448_abnormal_energy_balance | 0.67959151 |
109 | MP0002722_abnormal_immune_system | 0.67716341 |
110 | MP0008961_abnormal_basal_metabolism | 0.67534501 |
111 | MP0000358_abnormal_cell_content/ | 0.67388184 |
112 | MP0002970_abnormal_white_adipose | 0.67106315 |
113 | MP0003183_abnormal_peptide_metabolism | 0.66916094 |
114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66876378 |
115 | MP0000703_abnormal_thymus_morphology | 0.66687461 |
116 | MP0002419_abnormal_innate_immunity | 0.66354838 |
117 | MP0001853_heart_inflammation | 0.65996695 |
118 | MP0003953_abnormal_hormone_level | 0.64639408 |
119 | MP0000490_abnormal_crypts_of | 0.64335184 |
120 | MP0003011_delayed_dark_adaptation | 0.64297382 |
121 | MP0002429_abnormal_blood_cell | 0.64278193 |
122 | MP0009931_abnormal_skin_appearance | 0.63640385 |
123 | MP0003866_abnormal_defecation | 0.63314928 |
124 | MP0005023_abnormal_wound_healing | 0.63146850 |
125 | MP0009765_abnormal_xenobiotic_induced | 0.63068349 |
126 | MP0002877_abnormal_melanocyte_morpholog | 0.62830273 |
127 | MP0003566_abnormal_cell_adhesion | 0.62692381 |
128 | MP0004147_increased_porphyrin_level | 0.62615514 |
129 | MP0000343_altered_response_to | 0.61243767 |
130 | MP0005535_abnormal_body_temperature | 0.61221243 |
131 | MP0000013_abnormal_adipose_tissue | 0.60845131 |
132 | MP0002332_abnormal_exercise_endurance | 0.60736452 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.60644232 |
134 | MP0003329_amyloid_beta_deposits | 0.59955239 |
135 | MP0002080_prenatal_lethality | 0.59516065 |
136 | MP0010155_abnormal_intestine_physiology | 0.58564008 |
137 | MP0000003_abnormal_adipose_tissue | 0.58543427 |
138 | MP0002019_abnormal_tumor_incidence | 0.58530363 |
139 | MP0005266_abnormal_metabolism | 0.55650081 |
140 | MP0009672_abnormal_birth_weight | 0.54986843 |
141 | MP0000747_muscle_weakness | 0.54150804 |
142 | MP0000639_abnormal_adrenal_gland | 0.53180958 |
143 | MP0003303_peritoneal_inflammation | 0.52918774 |
144 | MP0003075_altered_response_to | 0.52036445 |
145 | MP0001661_extended_life_span | 0.51937411 |
146 | MP0003172_abnormal_lysosome_physiology | 0.51597691 |
147 | MP0005647_abnormal_sex_gland | 0.50801349 |
148 | MP0004947_skin_inflammation | 0.50754731 |
149 | MP0001533_abnormal_skeleton_physiology | 0.49041169 |
150 | MP0009384_cardiac_valve_regurgitation | 0.48127027 |
151 | MP0002135_abnormal_kidney_morphology | 0.47452973 |
152 | MP0000230_abnormal_systemic_arterial | 0.46000301 |
153 | MP0003724_increased_susceptibility_to | 0.45974468 |
154 | MP0008873_increased_physiological_sensi | 0.44167280 |
155 | MP0000477_abnormal_intestine_morphology | 0.43774320 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.95369385 |
2 | Deep venous thrombosis (HP:0002625) | 5.35179950 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.01107631 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.94040056 |
5 | Xanthomatosis (HP:0000991) | 4.91459236 |
6 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.91332953 |
7 | Abnormality of alanine metabolism (HP:0010916) | 4.91332953 |
8 | Hyperalaninemia (HP:0003348) | 4.91332953 |
9 | Hypoglycemic coma (HP:0001325) | 4.76177597 |
10 | Hypobetalipoproteinemia (HP:0003563) | 4.42961339 |
11 | Ketosis (HP:0001946) | 4.42463988 |
12 | Prolonged partial thromboplastin time (HP:0003645) | 4.10630715 |
13 | Myopathic facies (HP:0002058) | 3.94173527 |
14 | Hyperlipoproteinemia (HP:0010980) | 3.92040757 |
15 | Ketoacidosis (HP:0001993) | 3.90064565 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.87158473 |
17 | Hyperammonemia (HP:0001987) | 3.82809834 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75319665 |
19 | Complement deficiency (HP:0004431) | 3.70563131 |
20 | Hyperglycinuria (HP:0003108) | 3.69139666 |
21 | Hyperglycinemia (HP:0002154) | 3.63172494 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.58937970 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.58937970 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54347369 |
25 | Abnormality of glycolysis (HP:0004366) | 3.45294131 |
26 | Hypolipoproteinemia (HP:0010981) | 3.42613872 |
27 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.42203022 |
28 | Increased serum pyruvate (HP:0003542) | 3.42076141 |
29 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.41837775 |
30 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.41837775 |
31 | Single umbilical artery (HP:0001195) | 3.41837775 |
32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39864998 |
33 | Late onset (HP:0003584) | 3.33986267 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33388092 |
35 | Ragged-red muscle fibers (HP:0003200) | 3.29910508 |
36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28344309 |
37 | Joint hemorrhage (HP:0005261) | 3.22149400 |
38 | Gout (HP:0001997) | 3.19774667 |
39 | Fat malabsorption (HP:0002630) | 3.17069684 |
40 | Generalized aminoaciduria (HP:0002909) | 3.09101491 |
41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07872311 |
42 | Hypoglycemic seizures (HP:0002173) | 3.06818904 |
43 | Biconcave vertebral bodies (HP:0004586) | 3.04777660 |
44 | Hypoalphalipoproteinemia (HP:0003233) | 3.04721514 |
45 | Abnormality of the umbilical cord (HP:0010881) | 3.01179984 |
46 | Progressive muscle weakness (HP:0003323) | 3.00891917 |
47 | Fatigue (HP:0012378) | 2.95441227 |
48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.90149758 |
49 | Rhabdomyolysis (HP:0003201) | 2.86159223 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.85986589 |
51 | Abnormality of complement system (HP:0005339) | 2.80855530 |
52 | Epidermoid cyst (HP:0200040) | 2.78383767 |
53 | Hyperbilirubinemia (HP:0002904) | 2.75506288 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73360580 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.73360580 |
56 | Hypertensive crisis (HP:0100735) | 2.73314794 |
57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72983417 |
58 | Conjugated hyperbilirubinemia (HP:0002908) | 2.71894632 |
59 | Abnormal gallbladder physiology (HP:0012438) | 2.69780295 |
60 | Cholecystitis (HP:0001082) | 2.69780295 |
61 | Hypercholesterolemia (HP:0003124) | 2.69014142 |
62 | Vertebral compression fractures (HP:0002953) | 2.64753965 |
63 | Abnormality of methionine metabolism (HP:0010901) | 2.61567494 |
64 | Myocardial infarction (HP:0001658) | 2.50267448 |
65 | Skin nodule (HP:0200036) | 2.50088124 |
66 | Vacuolated lymphocytes (HP:0001922) | 2.49234139 |
67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46977073 |
68 | Constricted visual fields (HP:0001133) | 2.46432583 |
69 | Metabolic acidosis (HP:0001942) | 2.45100893 |
70 | Spontaneous hematomas (HP:0007420) | 2.43461089 |
71 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.43391665 |
72 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.43391665 |
73 | Oligomenorrhea (HP:0000876) | 2.43006921 |
74 | Delayed CNS myelination (HP:0002188) | 2.42270281 |
75 | Hyperglycemia (HP:0003074) | 2.38763942 |
76 | Anorexia (HP:0002039) | 2.36347586 |
77 | Symptomatic seizures (HP:0011145) | 2.35073152 |
78 | Microvesicular hepatic steatosis (HP:0001414) | 2.34325703 |
79 | Exercise-induced myalgia (HP:0003738) | 2.34119948 |
80 | Malnutrition (HP:0004395) | 2.32350285 |
81 | Abnormality of the tricuspid valve (HP:0001702) | 2.28137403 |
82 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.28112525 |
83 | Menorrhagia (HP:0000132) | 2.27453193 |
84 | Mucopolysacchariduria (HP:0008155) | 2.24285766 |
85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24285766 |
86 | Spastic diplegia (HP:0001264) | 2.23687591 |
87 | Abnormality of serum amino acid levels (HP:0003112) | 2.22931033 |
88 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22833374 |
89 | Steatorrhea (HP:0002570) | 2.18912012 |
90 | Hepatocellular carcinoma (HP:0001402) | 2.17767070 |
91 | Dysostosis multiplex (HP:0000943) | 2.14944309 |
92 | Pancreatitis (HP:0001733) | 2.13309954 |
93 | Mitral stenosis (HP:0001718) | 2.12773748 |
94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12187371 |
95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12187371 |
96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12187371 |
97 | Nausea (HP:0002018) | 2.10854707 |
98 | White forelock (HP:0002211) | 2.09432496 |
99 | Insulin resistance (HP:0000855) | 2.08351448 |
100 | Proximal tubulopathy (HP:0000114) | 2.08273328 |
101 | Myoglobinuria (HP:0002913) | 2.07534480 |
102 | Back pain (HP:0003418) | 2.06942435 |
103 | Lethargy (HP:0001254) | 2.04793653 |
104 | Decreased subcutaneous fat (HP:0001002) | 2.04025192 |
105 | Hydroxyprolinuria (HP:0003080) | 2.03760601 |
106 | Abnormality of proline metabolism (HP:0010907) | 2.03760601 |
107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03200429 |
108 | Purpura (HP:0000979) | 2.01520332 |
109 | Hemorrhage of the eye (HP:0011885) | 2.00812046 |
110 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.00368932 |
111 | Gingival bleeding (HP:0000225) | 1.99404886 |
112 | Systemic lupus erythematosus (HP:0002725) | 1.97663509 |
113 | Sensorimotor neuropathy (HP:0007141) | 1.97087016 |
114 | Abnormal gallbladder morphology (HP:0012437) | 1.96915663 |
115 | Esophageal varix (HP:0002040) | 1.96724520 |
116 | Irritability (HP:0000737) | 1.96519549 |
117 | Diaphragmatic weakness (HP:0009113) | 1.96029027 |
118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95062240 |
119 | Abnormal tarsal ossification (HP:0008369) | 1.95013009 |
120 | Abnormal cartilage morphology (HP:0002763) | 1.93414164 |
121 | Progressive external ophthalmoplegia (HP:0000590) | 1.92198604 |
122 | Distal lower limb amyotrophy (HP:0008944) | 1.91678755 |
123 | Brushfield spots (HP:0001088) | 1.91446030 |
124 | Bulbar palsy (HP:0001283) | 1.91047301 |
125 | Ileus (HP:0002595) | 1.90942239 |
126 | Protuberant abdomen (HP:0001538) | 1.90545790 |
127 | Neonatal onset (HP:0003623) | 1.89624878 |
128 | Cholelithiasis (HP:0001081) | 1.89357483 |
129 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89019677 |
130 | Thrombophlebitis (HP:0004418) | 1.88554483 |
131 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.88066446 |
132 | Polygenic inheritance (HP:0010982) | 1.87831080 |
133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.87645019 |
134 | Elevated alkaline phosphatase (HP:0003155) | 1.87123235 |
135 | Cortical visual impairment (HP:0100704) | 1.86797732 |
136 | Reduced antithrombin III activity (HP:0001976) | 1.86622631 |
137 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85642625 |
138 | Gastrointestinal dysmotility (HP:0002579) | 1.84589571 |
139 | Petechiae (HP:0000967) | 1.84561027 |
140 | Polycythemia (HP:0001901) | 1.83633560 |
141 | Abnormality of carpal bone ossification (HP:0006257) | 1.83301394 |
142 | Nephrolithiasis (HP:0000787) | 1.83040592 |
143 | Abnormal platelet function (HP:0011869) | 1.82554415 |
144 | Impaired platelet aggregation (HP:0003540) | 1.82554415 |
145 | Increased connective tissue (HP:0009025) | 1.82062111 |
146 | Vomiting (HP:0002013) | 1.81572588 |
147 | Abnormality of iron homeostasis (HP:0011031) | 1.81540707 |
148 | Increased purine levels (HP:0004368) | 1.81385541 |
149 | Hyperuricemia (HP:0002149) | 1.81385541 |
150 | Global brain atrophy (HP:0002283) | 1.81340963 |
151 | Flat acetabular roof (HP:0003180) | 1.79979109 |
152 | Hypertriglyceridemia (HP:0002155) | 1.78103699 |
153 | Patchy hypopigmentation of hair (HP:0011365) | 1.77281733 |
154 | Hypokinesia (HP:0002375) | 1.76137474 |
155 | Pulmonary embolism (HP:0002204) | 1.74285864 |
156 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72365510 |
157 | Conjunctival telangiectasia (HP:0000524) | 1.71518824 |
158 | Visceral angiomatosis (HP:0100761) | 1.71100969 |
159 | Hypoparathyroidism (HP:0000829) | 1.71017432 |
160 | Premature ovarian failure (HP:0008209) | 1.70658401 |
161 | Muscle stiffness (HP:0003552) | 1.70446212 |
162 | Reticulocytosis (HP:0001923) | 1.70203222 |
163 | Insomnia (HP:0100785) | 1.69546973 |
164 | Abnormality of reticulocytes (HP:0004312) | 1.68614719 |
165 | Increased cerebral lipofuscin (HP:0011813) | 1.67188648 |
166 | Heterochromia iridis (HP:0001100) | 1.66434637 |
167 | Reticulocytopenia (HP:0001896) | 1.65261212 |
168 | Muscle fiber inclusion bodies (HP:0100299) | 1.64820448 |
169 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.64256353 |
170 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63122279 |
171 | Abnormality of glycolipid metabolism (HP:0010969) | 1.63122279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.74715136 |
2 | BCKDK | 5.03325914 |
3 | TRIB3 | 4.17351499 |
4 | PKN2 | 3.75492437 |
5 | TAOK3 | 3.17022967 |
6 | SMG1 | 3.14572657 |
7 | SIK1 | 3.02921499 |
8 | INSRR | 2.90012677 |
9 | FLT3 | 2.63170378 |
10 | FGFR4 | 2.45494984 |
11 | MAP3K10 | 2.29324844 |
12 | PIM2 | 2.14550593 |
13 | STK16 | 1.98178695 |
14 | PTK6 | 1.96083609 |
15 | RIPK1 | 1.91373174 |
16 | VRK2 | 1.89046460 |
17 | ICK | 1.88625925 |
18 | PIK3CG | 1.82235736 |
19 | IRAK3 | 1.74857989 |
20 | MAP2K3 | 1.69688555 |
21 | CDK9 | 1.69065855 |
22 | TESK1 | 1.61192986 |
23 | ARAF | 1.58549775 |
24 | MAP4K1 | 1.55318085 |
25 | PRPF4B | 1.50123129 |
26 | KDR | 1.43391496 |
27 | EPHB1 | 1.43082539 |
28 | ZAP70 | 1.38397192 |
29 | LRRK2 | 1.38251012 |
30 | TYK2 | 1.34277668 |
31 | EEF2K | 1.31188202 |
32 | TAOK2 | 1.29284661 |
33 | MAPK11 | 1.22721599 |
34 | GRK6 | 1.16304188 |
35 | FGR | 1.16189567 |
36 | SCYL2 | 1.12994600 |
37 | MAPK15 | 1.12144254 |
38 | MAP3K7 | 1.11510792 |
39 | BTK | 1.10316887 |
40 | TTN | 1.09401498 |
41 | TGFBR2 | 1.07704683 |
42 | CDK12 | 1.04779919 |
43 | MAP3K1 | 1.04099015 |
44 | MAP3K11 | 1.03144402 |
45 | TBK1 | 1.03048391 |
46 | PTK2 | 1.00798666 |
47 | BUB1 | 0.98954607 |
48 | AURKA | 0.96754522 |
49 | JAK2 | 0.95925708 |
50 | CDK7 | 0.95771772 |
51 | IRAK4 | 0.93512054 |
52 | MAP2K2 | 0.93141465 |
53 | PRKD3 | 0.92906443 |
54 | PASK | 0.91382277 |
55 | JAK1 | 0.91331441 |
56 | STK10 | 0.89670888 |
57 | MAPKAPK3 | 0.87841160 |
58 | HIPK2 | 0.86194566 |
59 | FRK | 0.84365176 |
60 | CSK | 0.82071232 |
61 | RPS6KA4 | 0.81806481 |
62 | NEK9 | 0.81448572 |
63 | NME2 | 0.81271405 |
64 | MST1R | 0.76199048 |
65 | PBK | 0.74859762 |
66 | CDK8 | 0.74471493 |
67 | CAMK1D | 0.74220517 |
68 | CCNB1 | 0.74008790 |
69 | JAK3 | 0.73974205 |
70 | MAP3K3 | 0.72937733 |
71 | PDGFRA | 0.72723733 |
72 | TAOK1 | 0.71665019 |
73 | LIMK1 | 0.71474297 |
74 | IRAK2 | 0.71166558 |
75 | MTOR | 0.68143919 |
76 | TESK2 | 0.67499373 |
77 | EIF2AK1 | 0.67212512 |
78 | LMTK2 | 0.67117969 |
79 | DYRK1B | 0.65492134 |
80 | PDPK1 | 0.65111024 |
81 | LATS1 | 0.63907233 |
82 | PDK2 | 0.63165532 |
83 | RAF1 | 0.62539736 |
84 | CAMK2G | 0.62130967 |
85 | PRKD1 | 0.61664947 |
86 | BLK | 0.61322990 |
87 | DAPK1 | 0.60811811 |
88 | PRKAA2 | 0.60160480 |
89 | MUSK | 0.59931474 |
90 | RET | 0.59448320 |
91 | KIT | 0.58545413 |
92 | AKT2 | 0.58402204 |
93 | MAP3K8 | 0.57942755 |
94 | ITK | 0.57657946 |
95 | KSR2 | 0.55615881 |
96 | PRKCH | 0.52259870 |
97 | EPHA3 | 0.51868744 |
98 | BRSK2 | 0.51434453 |
99 | ILK | 0.50878932 |
100 | WNK4 | 0.50825625 |
101 | CSF1R | 0.50574448 |
102 | PAK2 | 0.48229054 |
103 | MET | 0.47812447 |
104 | MAP2K6 | 0.46748436 |
105 | PIK3CA | 0.45967442 |
106 | NEK1 | 0.45415136 |
107 | BMX | 0.45019712 |
108 | MAP2K4 | 0.44834983 |
109 | BRAF | 0.44785954 |
110 | PAK1 | 0.44595126 |
111 | MYLK | 0.43316163 |
112 | CAMK1G | 0.42950429 |
113 | TEC | 0.42705450 |
114 | PAK4 | 0.42532665 |
115 | MAP3K2 | 0.41961889 |
116 | MAP2K1 | 0.40968544 |
117 | CDK6 | 0.40817799 |
118 | CDK4 | 0.40699620 |
119 | PRKD2 | 0.40626758 |
120 | PDK1 | 0.40212696 |
121 | RPS6KA1 | 0.39708740 |
122 | RPS6KB1 | 0.38594261 |
123 | MAPKAPK2 | 0.38225166 |
124 | MAP3K5 | 0.37506246 |
125 | MAPK4 | 0.37009123 |
126 | PRKG2 | 0.36877391 |
127 | RPS6KB2 | 0.34820322 |
128 | MAPK12 | 0.34787915 |
129 | ERBB4 | 0.34170137 |
130 | SIK3 | 0.33588393 |
131 | DAPK3 | 0.32589476 |
132 | ATR | 0.32308000 |
133 | MAP3K6 | 0.32198442 |
134 | RPS6KC1 | 0.31416568 |
135 | RPS6KL1 | 0.31416568 |
136 | BRSK1 | 0.31070509 |
137 | OBSCN | 0.30658122 |
138 | CAMK2D | 0.30550701 |
139 | MOS | 0.30271062 |
140 | PRKCI | 0.29619317 |
141 | MAP3K13 | 0.28450999 |
142 | EPHA2 | 0.28372075 |
143 | RPS6KA2 | 0.27687310 |
144 | IKBKE | 0.26868223 |
145 | SYK | 0.26336769 |
146 | PRKAA1 | 0.26012047 |
147 | MARK3 | 0.25674122 |
148 | NLK | 0.25632096 |
149 | ALK | 0.24297393 |
150 | GSK3A | 0.24154397 |
151 | ABL2 | 0.23699896 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62464299 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33915848 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.08460554 |
4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.81518495 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78735286 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67171257 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57271679 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56432949 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56269408 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53376623 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35105378 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18431491 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18410413 |
14 | DNA replication_Homo sapiens_hsa03030 | 2.15949804 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14660476 |
16 | Base excision repair_Homo sapiens_hsa03410 | 2.00845922 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98570089 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97321622 |
19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.96565622 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.88890199 |
21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.86265723 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85418186 |
23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83000078 |
24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81236941 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.80199171 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77622713 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76908717 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72562010 |
29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66257904 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64449944 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61248123 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58042461 |
33 | Proteasome_Homo sapiens_hsa03050 | 1.57183488 |
34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54563947 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53318596 |
36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48240318 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.47323618 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43346681 |
39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42823089 |
40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41440691 |
41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40274314 |
42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38956353 |
43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38904107 |
44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37466436 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.31309362 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30669089 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21496086 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19673558 |
49 | Lysine degradation_Homo sapiens_hsa00310 | 1.15251270 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11923724 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11870890 |
52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11817771 |
53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10628243 |
54 | Spliceosome_Homo sapiens_hsa03040 | 1.09508296 |
55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07123168 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05193051 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02211112 |
58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01655616 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01248374 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95222880 |
61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93661491 |
62 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.93363874 |
63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92018929 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91312291 |
65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90748346 |
66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88338472 |
67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86952185 |
68 | Protein export_Homo sapiens_hsa03060 | 0.84160800 |
69 | Ribosome_Homo sapiens_hsa03010 | 0.83084956 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82551961 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81952103 |
72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81212496 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77630741 |
74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.77290867 |
75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74425782 |
76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73103409 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.72991617 |
78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67955743 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66538666 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64712372 |
81 | Mismatch repair_Homo sapiens_hsa03430 | 0.63903831 |
82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62189328 |
83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56179939 |
84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53445146 |
85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52673559 |
86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51587183 |
87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51526917 |
88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50600647 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49716639 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49208631 |
91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48432256 |
92 | RNA transport_Homo sapiens_hsa03013 | 0.48387876 |
93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42617453 |
94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42085593 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39292437 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38612578 |
97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38203432 |
98 | Apoptosis_Homo sapiens_hsa04210 | 0.36962440 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34777596 |
100 | Lysosome_Homo sapiens_hsa04142 | 0.34251329 |
101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34063192 |
102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33797157 |
103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33787000 |
104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31606748 |
105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31354468 |
106 | Purine metabolism_Homo sapiens_hsa00230 | 0.30015953 |
107 | Pertussis_Homo sapiens_hsa05133 | 0.29665050 |
108 | Shigellosis_Homo sapiens_hsa05131 | 0.28311522 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28150046 |
110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26393920 |
111 | Prion diseases_Homo sapiens_hsa05020 | 0.25093430 |
112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23777394 |
113 | Bladder cancer_Homo sapiens_hsa05219 | 0.23180336 |
114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22572879 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22402132 |
116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.21701479 |
117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21445647 |
118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.20954214 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20669946 |
120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20064337 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18562289 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.18541767 |
123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.18471829 |
124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.14243635 |
125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12517531 |
126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09590113 |
127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.06810782 |
128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06707944 |
129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05223416 |
130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04051242 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02755034 |
132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0538190 |
133 | Hepatitis C_Homo sapiens_hsa05160 | -0.0322477 |
134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0183792 |